You searched for "protection"
ENT in this issue...Multidisciplinary Teams
Joanne Rimmer, MBBS, MA(Hons) Cantab, FRCS(ORL-HNS), FRACS, Consultant Otolaryngologist / Rhinologist, Monash Health; Honorary Senior Lecturer, Department of Surgery, Monash University, Melbourne, Australia. E: rimmer.joanne@gmail.com The multidisciplinary team (MDT) has long been regarded as the gold standard in cancer care,...
Can we predict risk of adverse events preoperatively in patients undergoing head and neck cancer surgery?
Ed’s Choice reviews a paper aiming to create a reliable index to predict postoperative outcomes in head and neck cancer patients. This interesting study identifies variables that may assist in risk assessing prospective surgical candidates. There have been a few...
Bile acids and pharyngeal malignancy
Laryngopharyngeal reflux is a commonly described condition. There is strong evidence linking gastro-oesophageal reflux with oesophageal carcinomas. Gastric refluxate consists of gastric acid, pepsin and bile acids. The roles of pepsin and acidic conditions in the development of laryngopharyngeal carcinoma...
Unilateral vocal cord mobility impairment and laryngopulmonary physiology
The concept of iatrogenic recurrent laryngeal nerve injury following thyroid surgery is often considered with respect to voice change but its potential impact on airway physiology has thus far not been evaluated. A cross-sectional observational study reviewed 21 patients with...
What’s the risk of regrowth with partial (intracapsular) tonsillectomy
Partial (intracapsular) tonsillectomy is enjoying somewhat of a revival offering the potential for less postoperative pain and bleeding whilst relieving the obstructive element. The authors look at 303 patients, 82 of whom had partial tonsillectomy using coblation. They measured pre...
Sublingual immunotherapy
This paper reviews the recent European studies on sublingual immunotherapy (SLIT). SLIT is currently widely used in Europe and is gaining popularity in the United States. It is known that longer treatment is needed with SLIT compared with subcutaneous immunotherapy...
Superior semicircular canal volumetry
This study uses superior semicircular canal dehiscence (SSCD) volumetry to measure the size of SSCD. The authors imported high-resolution computed tomographic images of the temporal bone into segmentation software. They measured the dehiscence lengths and volumes on coronal images (instead...CI music: seeking perfection, accepting reality
Having just read about the challenges cochlear implant technology and music appreciation present, the musician Richard Reed beautifully illustrates the realities of this patient journey. An old friend of mine is an ardent music fan, and completely tone deaf. Long...Where ART meets Science: The Silence You Can Hear
Some moments have a sound you don’t hear with your ears but feel with your entire being. The artwork DS21008 (200 cm x 120 cm) captures such a moment: a Sunday morning in Maastricht, where the river Maas reflects the...New bone anchored hearing implant reaches clinical milestone
A new implant for bone-conduction hearing, BCI (Bone Conduction Implant), has been developed by Bo Håkansson and his team of researchers at Chalmers University of Technology and Sahlgrenska University Hospital, both in Gothenburg, Sweden. Unlike most bone-conduction devices used today,...Controlled clinical trial results for FDA-approved tinnitus treatment device Lenire published in Nature Communications
Nature Communications has published the peer-reviewed results of Neuromod Devices’ TENT-A3 (Treatment Evaluation of Neuromodulation for Tinnitus – Stage A3) clinical trial for the first and only FDA-approved bimodal tinnitus treatment device, Lenire.
